Invention Grant
- Patent Title: Benzoimidazoles as prolyl hydroxylase inhibitors
-
Application No.: US17103482Application Date: 2020-11-24
-
Publication No.: US11618744B2Publication Date: 2023-04-04
- Inventor: Frances Meredith Hocutt , Barry Eastman Leonard, Jr. , Hillary M. Peltier , Victor K. Phuong , Michael H. Rabinowitz , Mark D. Rosen , Kyle T. Tarantino , Hariharan Venkatesan , Lucy Xiumin Zhao
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Main IPC: C07D403/04
- IPC: C07D403/04 ; C07D235/24 ; C07D471/04 ; C07D473/40 ; C07D487/04 ; C07D403/14 ; C07D513/04
Abstract:
The present invention is directed to benzoimidazole compounds of the formula: and enantiomers, diastereomers, racemates, and pharmaceutically acceptable salts thereof. Compounds of the present invention are useful in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions modulated by prolyl hydroxylase activity.
Public/Granted literature
- US20210078978A1 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS Public/Granted day:2021-03-18
Information query
